204 related articles for article (PubMed ID: 31698924)
1. Apparent diffusion coefficient (ADC) values of serous, endometrioid, and clear cell carcinoma of the ovary: pathological correlation.
Ono T; Kishimoto K; Tajima S; Maeda I; Takagi M; Suzuki N; Mimura H
Acta Radiol; 2020 Jul; 61(7):992-1000. PubMed ID: 31698924
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer: correlation of apparent diffusion coefficient (ADC) with tumor cellularity and tumor grade.
Kishimoto K; Tajima S; Maeda I; Takagi M; Ueno T; Suzuki N; Nakajima Y
Acta Radiol; 2016 Aug; 57(8):1021-8. PubMed ID: 26486600
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary.
Morioka S; Kawaguchi R; Yamada Y; Iwai K; Yoshimoto C; Kobayashi H
J Ovarian Res; 2019 Feb; 12(1):20. PubMed ID: 30803452
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma.
Ma FH; Qiang JW; Zhang GF; Li HM; Cai SQ; Rao YM
J Ovarian Res; 2016 Jul; 9(1):40. PubMed ID: 27377917
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment maximum standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic factor for ovarian clear cell carcinoma and low-grade serous carcinoma.
Matsuura T; Otsuka I; Ouchi T; Ouchi E; Asano R; Miyasaka N
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):305-310. PubMed ID: 33678332
[TBL] [Abstract][Full Text] [Related]
7. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
[TBL] [Abstract][Full Text] [Related]
8. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer?
Yan B; Zhao T; Liang X; Niu C; Ding C
Acta Radiol; 2018 Mar; 59(3):363-370. PubMed ID: 28696169
[TBL] [Abstract][Full Text] [Related]
9. Whole-tumor ADC histogram analysis for differentiating endometriosis-related tumors: seromucinous borderline tumor, clear cell carcinoma and endometrioid carcinoma.
Lu J; Zhao S; Ma F; Li H; Li Y; Qiang J
Abdom Radiol (NY); 2023 Feb; 48(2):724-732. PubMed ID: 36401131
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma.
Mori T; Kato H; Kawaguchi M; Hatano Y; Ishihara T; Noda Y; Hyodo F; Matsuo M; Furui T; Morishige KI
Eur Radiol; 2022 Jun; 32(6):4128-4136. PubMed ID: 35061079
[TBL] [Abstract][Full Text] [Related]
11. The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.
Lu L; Wang S; Zhu Q; Qu Y; Gu W; Ning Y; Chen X; Wang Y
Pathol Res Pract; 2018 Aug; 214(8):1087-1094. PubMed ID: 29866423
[TBL] [Abstract][Full Text] [Related]
12. Histogram Analysis of Apparent Diffusion Coefficient on Diffusion Weighted Magnetic Resonance Imaging in Differentiation between Low and High Grade Serous Ovarian Cancer.
Liu X; Wang T; Wang Y; Wang J; Jin J; Zhang G; Zhang H
Curr Med Imaging; 2023; 19(2):167-174. PubMed ID: 35585829
[TBL] [Abstract][Full Text] [Related]
13. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
[TBL] [Abstract][Full Text] [Related]
14. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
15. Diffusion-weighted MRI of epithelial ovarian cancers: correlation of apparent diffusion coefficient values with histologic grade and surgical stage.
Oh JW; Rha SE; Oh SN; Park MY; Byun JY; Lee A
Eur J Radiol; 2015 Apr; 84(4):590-5. PubMed ID: 25623826
[TBL] [Abstract][Full Text] [Related]
16. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
17. Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.
Li M; Li H; Liu F; Bi R; Tu X; Chen L; Ye S; Cheng X
J Ovarian Res; 2017 Feb; 10(1):9. PubMed ID: 28187748
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial Ovarian Carcinoma.
Fridley BL; Dai J; Raghavan R; Li Q; Winham SJ; Hou X; Weroha SJ; Wang C; Kalli KR; Cunningham JM; Lawrenson K; Gayther SA; Goode EL
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1101-1109. PubMed ID: 29967001
[No Abstract] [Full Text] [Related]
19. [Clinicopathological study of SET subtype of ovarian high-grade serous carcinoma].
Sun YW; Shen DH; Cui SS; He HJ; Zhang XL; Wang W; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):595-600. PubMed ID: 31550775
[No Abstract] [Full Text] [Related]
20. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
Morency E; Leitao MM; Soslow RA
Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
